SCHEMBL6258752

SCHEMBL6258752

CCc1cccc2c1C(=O)N(C(CC(=O)O)C(=O)O)C2=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.49
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
TP53 P04637 1/20 0.49
GLA P06280 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
HPGD P15428 1/20 0.49
ALOX12 P18054 1/20 0.49
NFKB1 P19838 1/20 0.49
APEX1 P27695 1/20 0.49
MAPK1 P28482 1/20 0.49
HSD17B10 Q99714 1/20 0.49
GAA P10253 2/20 0.47
KMT2A Q03164 3/20 0.43
ANPEP P15144 1/20 0.41
DPP4 P27487 1/20 0.41
DNMT1 P26358 3/20 0.41
CYP2C19 P33261 1/20 0.41
DNMT3B Q9UBC3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6256608 0.91 POLB (0.46) POLBALDH1A1KDM4ETP53GLA
SCHEMBL6259357 0.90 ALDH1A1 (0.45) POLBALDH1A1KDM4ETP53GLA
SCHEMBL6261421 0.90 POLB (0.49) POLBALDH1A1KDM4ETP53GLA
SCHEMBL6258971 0.89 POLB (0.44) POLBALDH1A1KDM4ETP53GLA
SCHEMBL6255737 0.85 POLB (0.50) POLBALDH1A1KDM4ETP53GLA
SCHEMBL6270550 0.85 ALDH1A1 (0.58) POLBALDH1A1KDM4ETP53GLA
SCHEMBL6257316 0.83 KDM4E (0.51) POLBALDH1A1KDM4ETP53GLA
SCHEMBL6259492 0.83 POLB (0.48) POLBALDH1A1KDM4ETP53GLA
SCHEMBL6258804 0.82 KMT2A (0.57) POLBALDH1A1KDM4ETP53GLA
SCHEMBL6260772 0.82 ALDH1A1 (0.47) POLBALDH1A1KDM4ETP53GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163219-B1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORP (US) 2005-10-12 EP disclosed
US-6380239-B1 FOR THERAPY OF ARTHRITIS, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, REPERFUSION INJURY, INFLAMMATORY BOWEL DISEASE, CROHN'S DISEASE, ULCERATIVE COLITIS, SYSTEMIC LUPUS ERYTHREMATOSIS, SCLERODERMA, APHTHOUS ULCERS, ASTHMA CELGENE CORPORATION 2002-04-30 US disclosed
CN-1342146-A Substituted 1-oxo-and 1, 3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels CELGENE CORP (US) 2002-03-27 CN disclosed
EP-1163219-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2001-12-19 EP disclosed
WO-2000055134-A1 SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS CELGENE CORPORATION (US) 2000-09-21 WO disclosed